Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Epilepsy; Paediatric Partial Onset Seizures
View Full LandscapeTarget Indication
Epilepsy; Paediatric Partial Onset Seizures
Clinical Trial
NCT00566254Last updated: 12/23/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Zonegran
Zonegran is indicated as: monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy; adjunctive therapy in the treatment of partial seizures, with or without secondary generalisation, in adults, adolescents, and children aged six years and above.
View on EMA